Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INM |
---|---|---|
09:32 ET | 5415 | 1.995 |
09:33 ET | 3585 | 2 |
09:35 ET | 277 | 1.9801 |
09:37 ET | 3587 | 1.9951 |
09:39 ET | 250 | 2.0062 |
09:42 ET | 5123 | 1.98 |
09:44 ET | 50823 | 1.8805 |
09:46 ET | 27038 | 1.94 |
09:48 ET | 300 | 1.93 |
09:50 ET | 600 | 1.94 |
09:51 ET | 100 | 1.96 |
09:53 ET | 200 | 1.94 |
09:57 ET | 1907 | 1.96 |
10:00 ET | 1096 | 1.9301 |
10:02 ET | 1179 | 1.9 |
10:04 ET | 2000 | 1.91 |
10:06 ET | 4632 | 1.8901 |
10:08 ET | 1490 | 1.91 |
10:09 ET | 3491 | 1.9136 |
10:11 ET | 14558 | 1.8901 |
10:13 ET | 300 | 1.8901 |
10:15 ET | 4400 | 1.92 |
10:18 ET | 200 | 1.94 |
10:20 ET | 2500 | 1.97 |
10:22 ET | 100 | 1.97 |
10:24 ET | 5238 | 2.0405 |
10:26 ET | 600 | 2.0699 |
10:27 ET | 2415 | 2.0699 |
10:29 ET | 250 | 2.05 |
10:33 ET | 6876 | 1.97 |
10:36 ET | 3000 | 1.9771 |
10:38 ET | 300 | 2.0099 |
10:44 ET | 604 | 2.01 |
10:45 ET | 367 | 1.9801 |
10:47 ET | 2611 | 2.0099 |
10:51 ET | 100 | 2 |
10:56 ET | 323 | 2.01 |
11:00 ET | 807 | 2 |
11:02 ET | 1275 | 2 |
11:05 ET | 100 | 2.01 |
11:07 ET | 300 | 2.01 |
11:09 ET | 3100 | 2.0176 |
11:12 ET | 4312 | 2.0599 |
11:14 ET | 500 | 2.0699 |
11:16 ET | 500 | 2.0697 |
11:18 ET | 4000 | 2.07 |
11:21 ET | 1400 | 2.04 |
11:23 ET | 710 | 2.0204 |
11:25 ET | 500 | 2.04 |
11:30 ET | 900 | 2.02 |
11:39 ET | 5687 | 2 |
11:41 ET | 2726 | 2.02 |
11:43 ET | 2900 | 2 |
11:45 ET | 4050 | 1.9919 |
11:48 ET | 1000 | 2.02 |
11:50 ET | 380 | 1.9931 |
11:52 ET | 4059 | 1.98 |
11:59 ET | 2000 | 1.9815 |
12:01 ET | 1000 | 2.0082 |
12:03 ET | 6345 | 1.9918 |
12:06 ET | 3580 | 2 |
12:08 ET | 200 | 2.04 |
12:24 ET | 537 | 2.01 |
12:26 ET | 500 | 2.0101 |
12:28 ET | 100 | 2.0101 |
12:32 ET | 6059 | 2.025 |
12:33 ET | 3482 | 2.025 |
12:44 ET | 3000 | 2.0361 |
12:50 ET | 628 | 2.0383 |
12:57 ET | 4366 | 2 |
01:04 ET | 6612 | 2 |
01:06 ET | 4300 | 2 |
01:13 ET | 4906 | 1.9911 |
01:15 ET | 116 | 1.9952 |
01:27 ET | 1100 | 1.9997 |
01:31 ET | 100 | 1.99 |
01:40 ET | 576 | 1.9865 |
01:44 ET | 1000 | 1.9816 |
01:58 ET | 363 | 2.015 |
02:03 ET | 475 | 2.03 |
02:18 ET | 681 | 2.005 |
02:32 ET | 3200 | 1.99 |
02:36 ET | 140 | 1.9917 |
02:41 ET | 495 | 2 |
02:43 ET | 179 | 1.99 |
02:45 ET | 1000 | 1.9962 |
02:54 ET | 3600 | 2.0199 |
02:56 ET | 15100 | 2.0199 |
02:57 ET | 4599 | 2 |
03:03 ET | 500 | 2.024 |
03:08 ET | 4000 | 2.0323 |
03:10 ET | 6763 | 2.0331 |
03:12 ET | 3500 | 2.0101 |
03:15 ET | 1187 | 2.03 |
03:17 ET | 770 | 2.0127 |
03:24 ET | 6550 | 2.0764 |
03:26 ET | 4007 | 2.06 |
03:28 ET | 8299 | 2.0499 |
03:32 ET | 1200 | 2.0301 |
03:44 ET | 13789 | 2.06 |
03:46 ET | 6153 | 2.07 |
03:48 ET | 5578 | 2.08 |
03:50 ET | 6170 | 2.085 |
03:51 ET | 16060 | 2.12 |
03:53 ET | 10356 | 2.15 |
03:55 ET | 4763 | 2.14 |
03:57 ET | 14076 | 2.17 |
04:00 ET | 28894 | 2.2 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
InMed Pharmaceuticals Inc | 2.4M | -0.1x | --- |
Baudax Bio Inc | 1.7M | 0.8x | --- |
Statera Biopharma Inc | 2.3M | 0.0x | --- |
Senestech Inc | 2.6M | -0.3x | --- |
Midatech Pharma PLC | 2.9M | -0.1x | --- |
Kaleido Biosciences Inc | 8.5K | 0.0x | --- |
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company that is engaged in the development, manufacturing and commercialization of rare cannabinoids. It is developing a pipeline of prescription-based products, including rare cannabinoids and novel cannabinoid analogs, targeting the treatment of diseases with unmet medical needs (Product Candidates). The Company’s segments include InMed Pharmaceuticals and BayMedica. The InMed Pharmaceuticals segment is engaged in research and development of cannabinoid-based pharmaceuticals products. The BayMedica segment is focused on developing manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 provides both neuroprotection and reduces intraocular pressure in the eye.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4M |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 1.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.92 |
EPS | $-30.15 |
Book Value | $13.95 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,265.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.